Cargando…
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents
Identifying patients who may benefit from targeted therapy is an urgent clinical issue in prostate cancer (PCa). We investigated the molecular relationship between TMPRSS2-ERG (T2E) fusion gene and insulin-like growth factor receptor (IGF-1R) to optimize the use of IGF-1R inhibitors. IGF-1R was anal...
Autores principales: | Mancarella, Caterina, Casanova-Salas, Irene, Calatrava, Ana, Ventura, Selena, Garofalo, Cecilia, Rubio-Briones, José, Magistroni, Vera, Manara, Maria Cristina, López-Guerrero, José Antonio, Scotlandi, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599293/ https://www.ncbi.nlm.nih.gov/pubmed/25906745 |
Ejemplares similares
-
Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
por: Mancarella, Caterina, et al.
Publicado: (2017) -
MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer
por: Casanova-Salas, Irene, et al.
Publicado: (2015) -
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R
por: Mancarella, Caterina, et al.
Publicado: (2018) -
Novel Regulators of the IGF System in Cancer
por: Mancarella, Caterina, et al.
Publicado: (2021) -
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling
por: Manara, Maria Cristina, et al.
Publicado: (2016)